Voyager and Exobiosphere Add Two ISS Missions, Expanding Microgravity Drug Discovery
VOYG sits 80% above its 52-week low of $17.41 on elevated volume (6.7× avg).
Summary
Voyager Technologies and Exobiosphere announced two additional research campaigns aboard the ISS, expanding their existing agreement. The first campaign launches in June 2027 and the second in August-September 2027, following the OHTS platform installation in April 2027. Voyager Europe will manage the missions under the master services agreement. This builds on Voyager's recent momentum, including the Astrobotic acquisition and strong Q2 results, and signals growing commercial demand for microgravity drug discovery. The recurring nature of these missions suggests a shift toward a schedulable service model, which could support future revenue growth.
At the time of this announcement, VOYG was trading at $31.40 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $17.41 to $52.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.